$CUTR
CUTERA INC

2015 Q4 Form 10-K Financial Statement

#000143774917004609 Filed on March 15, 2017

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q2
Revenue $30.04M $23.09M $22.56M
YoY Change 17.82% 23.28% 27.3%
Cost Of Revenue $12.15M $9.594M $9.687M
YoY Change 3.99% 20.91% 23.43%
Gross Profit $17.90M $13.49M $12.88M
YoY Change 29.5% 25.02% 30.38%
Gross Profit Margin 59.57% 58.44% 57.07%
Selling, General & Admin $13.09M $11.73M $12.08M
YoY Change 2.55% 9.58% 19.73%
% of Gross Profit 73.13% 86.92% 93.82%
Research & Development $2.812M $2.748M $2.728M
YoY Change 6.15% 4.57% 4.04%
% of Gross Profit 15.71% 20.37% 21.19%
Depreciation & Amortization $280.0K $290.0K $290.0K
YoY Change -20.0% -12.12% -12.12%
% of Gross Profit 1.56% 2.15% 2.25%
Operating Expenses $15.90M $14.48M $14.81M
YoY Change 3.17% 8.59% 16.5%
Operating Profit $1.997M -$984.0K -$1.932M
YoY Change -225.44% -61.24% -31.85%
Interest Expense $70.00K $70.00K $90.00K
YoY Change 600.0% -10.0%
% of Operating Profit 3.51%
Other Income/Expense, Net $105.0K $84.00K $96.00K
YoY Change 1212.5% -30.43%
Pretax Income $2.102M -$900.0K -$1.836M
YoY Change -232.7% -64.55% -31.92%
Income Tax $52.00K $57.00K $53.00K
% Of Pretax Income 2.47%
Net Earnings $2.050M -$957.0K -$1.889M
YoY Change -226.15% -63.69% -31.08%
Net Earnings / Revenue 6.82% -4.15% -8.37%
Basic Earnings Per Share $0.16 -$0.07 -$0.13
Diluted Earnings Per Share $0.15 -$0.07 -$0.13
COMMON SHARES
Basic Shares Outstanding 12.98M 13.83M 14.44M
Diluted Shares Outstanding 13.59M 13.83M 14.44M

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $48.40M $47.70M $66.30M
YoY Change -40.32% -40.89% -18.75%
Cash & Equivalents $10.87M $10.06M $11.63M
Short-Term Investments $37.50M $37.70M $54.70M
Other Short-Term Assets $1.700M $2.100M $1.600M
YoY Change 6.25% 10.53% -11.11%
Inventory $12.08M $13.48M $13.52M
Prepaid Expenses
Receivables $11.67M $9.013M $8.919M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $73.83M $72.28M $90.43M
YoY Change -29.61% -29.48% -10.47%
LONG-TERM ASSETS
Property, Plant & Equipment $1.473M $1.386M $1.512M
YoY Change 0.82% 6.62% 16.31%
Goodwill $1.339M $1.339M $1.339M
YoY Change 0.0%
Intangibles $143.0K $227.0K $332.0K
YoY Change -75.97%
Long-Term Investments
YoY Change
Other Assets $384.0K $392.0K $351.0K
YoY Change 6.37% 30.67% -12.25%
Total Long-Term Assets $3.689M $3.635M $3.817M
YoY Change -8.35% -17.39% -18.79%
TOTAL ASSETS
Total Short-Term Assets $73.83M $72.28M $90.43M
Total Long-Term Assets $3.689M $3.635M $3.817M
Total Assets $77.52M $75.92M $94.24M
YoY Change -28.83% -28.98% -10.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.959M $2.659M $3.597M
YoY Change -36.46% -1.52% 79.85%
Accrued Expenses $13.83M $12.23M $10.31M
YoY Change 25.68% 35.93% 37.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.43M $23.36M $22.56M
YoY Change 6.28% 14.52% 24.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $584.0K $538.0K $699.0K
YoY Change -36.93% -90.39% -87.74%
Total Long-Term Liabilities $584.0K $538.0K $699.0K
YoY Change -36.93% -90.39% -87.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.43M $23.36M $22.56M
Total Long-Term Liabilities $584.0K $538.0K $699.0K
Total Liabilities $27.48M $26.58M $26.55M
YoY Change -3.24% 1.46% 11.09%
SHAREHOLDERS EQUITY
Retained Earnings -$29.67M -$31.72M -$30.77M
YoY Change 17.6%
Common Stock $79.80M $81.06M $98.44M
YoY Change -24.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $50.03M $49.33M $67.69M
YoY Change
Total Liabilities & Shareholders Equity $77.52M $75.92M $94.24M
YoY Change -28.83% -28.98% -10.84%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q2
OPERATING ACTIVITIES
Net Income $2.050M -$957.0K -$1.889M
YoY Change -226.15% -63.69% -31.08%
Depreciation, Depletion And Amortization $280.0K $290.0K $290.0K
YoY Change -20.0% -12.12% -12.12%
Cash From Operating Activities $3.890M -$620.0K $1.380M
YoY Change 745.65% -50.79% -154.76%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K -$20.00K -$270.0K
YoY Change -85.29% -81.82% 575.0%
Acquisitions
YoY Change
Other Investing Activities -$20.00K $16.94M $7.780M
YoY Change -99.05% 1288.52% 231.06%
Cash From Investing Activities -$60.00K $16.92M $7.510M
YoY Change -97.54% 1410.71% 226.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.010M -17.88M -10.72M
YoY Change -852.5% -2983.87% -2921.05%
NET CHANGE
Cash From Operating Activities 3.890M -620.0K 1.380M
Cash From Investing Activities -60.00K 16.92M 7.510M
Cash From Financing Activities -3.010M -17.88M -10.72M
Net Change In Cash 820.0K -1.580M -1.830M
YoY Change -151.9% -429.17% -1243.75%
FREE CASH FLOW
Cash From Operating Activities $3.890M -$620.0K $1.380M
Capital Expenditures -$50.00K -$20.00K -$270.0K
Free Cash Flow $3.940M -$600.0K $1.650M
YoY Change 392.5% -47.83% -166.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1359000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4286000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
4213000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1644000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-1229000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-2051000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
2050000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-957000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-1889000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3644000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
2577000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-4440000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-10612000
CY2016Q4 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
49000
CY2016Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-204000
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
166000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
217000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
144000
CY2015Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
105000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
96000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
323000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
293000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
226000
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
17468000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
16204000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
17421000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
14645000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
15900000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
14475000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
14808000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
13621000
CY2016 us-gaap Operating Expenses
OperatingExpenses
65738000
CY2015 us-gaap Operating Expenses
OperatingExpenses
58804000
CY2014 us-gaap Operating Expenses
OperatingExpenses
53992000
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4445000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1539000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1416000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2171000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1997000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-984000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1932000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3602000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
2397000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-4521000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-10619000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-94000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2141000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1912000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
5000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
35000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
189000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17000
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
3000
CY2015 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
7000
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
4000
CY2016 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
10000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-94000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-46000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-46000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3527000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2354000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
380000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
384000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
30000
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-87000
CY2014 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-42000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
27000
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-94000
CY2014 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-46000
CY2016 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
15000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
582000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
584000
CY2014 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1018000
CY2015 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
227000
CY2014 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
206000
CY2016 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
618000
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2014 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4873000
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40085000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3758000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
25810000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2251000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1675000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
156000
CY2016 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
37693000
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10111000
CY2015 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
11079000
CY2015 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
23697000
CY2014 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
44146000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
537000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
746000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
734000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
20000
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
35918000
CY2014 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
12354000
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
21171000
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
26915000
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
9008000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9060000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8454000
CY2016Q4 cutr Available For Sale Securities Debt Maturities Year Two Through Three Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughThreeFairValue
3503000
CY2016 cutr Average Maturity Period Of Interest Rate Of Auction Securities
AverageMaturityPeriodOfInterestRateOfAuctionSecurities
P1Y180D
CY2016 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
6700000
CY2015 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
6200000
CY2014 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
6600000
CY2016Q4 cutr Deferred Tax Assets Foreign
DeferredTaxAssetsForeign
377000
CY2015Q4 cutr Deferred Tax Assets Foreign
DeferredTaxAssetsForeign
350000
CY2016Q4 cutr Disclosure On Geographic Areas Long Lived Assets In Entity S Country Of Domicile Percent
DisclosureOnGeographicAreasLongLivedAssetsInEntitySCountryOfDomicilePercent
0.98
CY2016 cutr Effective Income Tax Rate Reconciliation True Ups Percent
EffectiveIncomeTaxRateReconciliationTrueUpsPercent
-0.0067
CY2015 cutr Effective Income Tax Rate Reconciliation True Ups Percent
EffectiveIncomeTaxRateReconciliationTrueUpsPercent
CY2014 cutr Effective Income Tax Rate Reconciliation True Ups Percent
EffectiveIncomeTaxRateReconciliationTrueUpsPercent
CY2016Q4 cutr Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
6002000
CY2015Q4 cutr Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
6002000
CY2016 cutr Inventories Estimated Useful Lives
InventoriesEstimatedUsefulLives
P2Y
CY2016 cutr Longterm Investment Marketable Period
LongtermInvestmentMarketablePeriod
P1Y
CY2016 cutr Maturity Of Money Market Fund
MaturityOfMoneyMarketFund
P3Y
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1907000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2461000
CY2015Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1819000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1473000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13775000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-72000
CY2014 cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
52046
CY2015 cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
92379
CY2016 cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
495050
CY2014 cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
764394
CY2015 cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
430580
CY2016 cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
1018005
CY2014 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved
200000
CY2015 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved
1300000
CY2014 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
486300
CY2015 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
129000
CY2016 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
162000
CY2016Q4 cutr Total Cash Cash Equivalents And Marketable Securities
TotalCashCashEquivalentsAndMarketableSecurities
54074000
CY2015Q4 cutr Total Cash Cash Equivalents And Marketable Securities
TotalCashCashEquivalentsAndMarketableSecurities
48407000
CY2016Q4 cutr Total Cash Cash Equivalents And Marketable Securities Amortized Cost
TotalCashCashEquivalentsAndMarketableSecuritiesAmortizedCost
54086000
CY2015Q4 cutr Total Cash Cash Equivalents And Marketable Securities Amortized Cost
TotalCashCashEquivalentsAndMarketableSecuritiesAmortizedCost
48446000
CY2016 cutr Uncertain Income Tax Position Minimum Rate
UncertainIncomeTaxPositionMinimumRate
0.5
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2598000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1959000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16547000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11669000
CY2016Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
168000
CY2015Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
182000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17397000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13834000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9036000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
7726000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7153000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-89000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
88114000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6981000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79782000
CY2016 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
619000
CY2015 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000000
CY2014 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
156000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3299000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4084000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3713000
CY2016 us-gaap Advertising Expense
AdvertisingExpense
1300000
CY2015 us-gaap Advertising Expense
AdvertisingExpense
1200000
CY2014 us-gaap Advertising Expense
AdvertisingExpense
1600000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3713000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4084000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3299000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
141000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
452000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
773000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
244000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2988000
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3825000
CY2016Q4 us-gaap Assets
Assets
91854000
CY2015Q4 us-gaap Assets
Assets
77518000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
87849000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
73829000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
40299000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
21000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
46000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
36796000
CY2016 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
801000
CY2015 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
285000
CY2014 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
70000
CY2016Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
1400000
CY2015Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
862000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
993000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
367000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
6000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
266000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
354000
CY2016Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
492000
CY2015Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
374000
CY2016Q4 us-gaap Cash
Cash
6672000
CY2015Q4 us-gaap Cash
Cash
9830000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10868000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9803000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16242000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6439000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2907000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1065000
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
10868000
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13775000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13773389
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12980807
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13773389
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12980807
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2594000
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4534000
CY2014 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10658000
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments and accounts receivable. The Company&#x2019;s cash and cash equivalents are primarily invested in deposits and money market accounts with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> exceed the amount of insurance provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. The Company has not experienced any losses on its deposits of cash and cash equivalents. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company invests in debt instruments, including bonds of the U.S. Government, its agencies and municipalities. The Company has also invested in other high grade investments such as commercial paper and corporate bonds. By policy, the Company restricts its exposure to any single issuer by imposing concentration limits. To minimize the exposure due to adverse shifts in interest rates, the Company maintains investments at an average maturity of generally less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eighteen</div> months.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accounts receivable are typically unsecured and are derived from revenue earned from worldwide customers. The Company performs credit evaluations of its customers and maintains reserves for potential credit losses. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer who represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%,</div> respectively,&nbsp;of the Company&#x2019;s net accounts receivable. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> domestic revenue accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">52%,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%,</div> respectively, of total revenue, while international revenue accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">48%,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55%,</div> respectively, of total revenue. No single customer represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total revenue for any of the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014.</div> &nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is also subject to risks common to companies in the medical device industry, including, but not limited to, new technology innovations, dependence on key personnel, dependence on key suppliers, protection of proprietary technology, product liability, Food and Drug Administration and/or international regulatory approvals required for new products and compliance with government regulations.&nbsp;</div></div></div></div></div>
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
40149000
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
32402000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
26796000
CY2016Q4 us-gaap Cost Of Revenue
CostOfRevenue
15962000
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
12538000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
11472000
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
9949000
CY2015Q4 us-gaap Cost Of Revenue
CostOfRevenue
12145000
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
9594000
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
9687000
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
9052000
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
49921000
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
40478000
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
34765000
CY2016 us-gaap Cost Of Services
CostOfServices
9772000
CY2015 us-gaap Cost Of Services
CostOfServices
8076000
CY2014 us-gaap Cost Of Services
CostOfServices
7969000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-7000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-7000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
131000
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
218000
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
110000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
147000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
234000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
122000
CY2015Q3 us-gaap Gross Profit
GrossProfit
13491000
CY2015Q2 us-gaap Gross Profit
GrossProfit
12876000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
16000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
23000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
19000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-24000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
33000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
32000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
22000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-55000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
65000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-22000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
97000
CY2015Q4 us-gaap Deferred Revenue
DeferredRevenue
10469000
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
12949000
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
9431000
CY2016 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
12344000
CY2015 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
10378000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8394000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8638000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1705000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2287000
CY2016 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
13382000
CY2015 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
12858000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
32128000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27966000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
292000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
247000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
377000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
350000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
377000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
350000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15487000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14231000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
95000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5000
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2627000
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1105000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
9006000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4477000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1486000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2462000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
2160000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
4679000
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
890000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
657000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31751000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27616000
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
85000
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
103000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
85000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
103000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
262000
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
244000
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
211000
CY2016 us-gaap Depreciation
Depreciation
841000
CY2015 us-gaap Depreciation
Depreciation
734000
CY2014 us-gaap Depreciation
Depreciation
562000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
982000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1186000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1336000
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0523
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0501
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.021
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2457
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3163
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3658
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0016
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0147
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0104
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.1592
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.0724
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.1436
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.1919
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0556
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0608
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0458
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0178
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.1456
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0194
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0162
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0925
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
0
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
0
CY2014 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
0
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4661000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4520000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2000
CY2016Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3010000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2716000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3997000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3220000
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3189000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2937000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3014000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2989000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12943000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12129000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11203000
CY2016Q4 us-gaap Goodwill
Goodwill
1339000
CY2015Q4 us-gaap Goodwill
Goodwill
1339000
CY2016Q4 us-gaap Goodwill Gross
GoodwillGross
1339000
CY2015Q4 us-gaap Goodwill Gross
GoodwillGross
1339000
CY2016Q4 us-gaap Gross Profit
GrossProfit
21913000
CY2016Q3 us-gaap Gross Profit
GrossProfit
17743000
CY2016Q2 us-gaap Gross Profit
GrossProfit
16005000
CY2016Q1 us-gaap Gross Profit
GrossProfit
12474000
CY2015Q4 us-gaap Gross Profit
GrossProfit
17897000
CY2015Q1 us-gaap Gross Profit
GrossProfit
10019000
CY2016 us-gaap Gross Profit
GrossProfit
68135000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-900000
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2102000
CY2015 us-gaap Gross Profit
GrossProfit
54283000
CY2014 us-gaap Gross Profit
GrossProfit
43373000
CY2014 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
650000
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2015 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2207000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4588000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10592000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
513000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
360000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
199000
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4241000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1705000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1199000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2027000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1836000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3594000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2720000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4228000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10393000
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
143000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
212000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
219000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4100000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1600000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3300000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
222000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
160000
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
225000
CY2016 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
639000
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1124000
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1263000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3458000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3392000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
32646000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4899000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
536000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1460000
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-14000
CY2015 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
37000
CY2014 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
37000
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3461000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2687000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1650000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-826000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-241000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-239000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
143000
CY2016Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1341000
CY2015Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1482000
CY2016 us-gaap Interest Paid
InterestPaid
43000
CY2015 us-gaap Interest Paid
InterestPaid
20000
CY2014 us-gaap Interest Paid
InterestPaid
26000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2400000
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2300000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4011000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2319000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1410000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2899000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1090000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1982000
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4000
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
23000
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
37000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-329000
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-289000
CY2014 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-285000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
432000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4096000
CY2016Q4 us-gaap Inventory Net
InventoryNet
14977000
CY2015Q4 us-gaap Inventory Net
InventoryNet
12078000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10966000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7982000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1500000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1500000
CY2016Q4 us-gaap Liabilities
Liabilities
30844000
CY2015Q4 us-gaap Liabilities
Liabilities
27484000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
91854000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77518000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28389000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4307000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-30222000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24431000
CY2016Q4 us-gaap Litigation Reserve
LitigationReserve
138000
CY2015Q4 us-gaap Litigation Reserve
LitigationReserve
110000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
40299000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
37539000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5611000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1992000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2914000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2712000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2709000
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2812000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2748000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2728000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2445000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11232000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10733000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10543000
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
313000
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
198000
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
144000
CY2016Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2897000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27046000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29672000
CY2016Q4 us-gaap Revenues
Revenues
37875000
CY2016Q3 us-gaap Revenues
Revenues
30281000
CY2016Q2 us-gaap Revenues
Revenues
27477000
CY2016Q1 us-gaap Revenues
Revenues
22423000
CY2015Q4 us-gaap Revenues
Revenues
30042000
CY2015Q3 us-gaap Revenues
Revenues
23085000
CY2015Q2 us-gaap Revenues
Revenues
22563000
CY2015Q1 us-gaap Revenues
Revenues
19071000
CY2016 us-gaap Revenues
Revenues
118056000
CY2015 us-gaap Revenues
Revenues
94761000
CY2014 us-gaap Revenues
Revenues
78138000
CY2016Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2373000
CY2015Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1935000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
99028000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77022000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8716000
CY2015Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9899000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8790000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9066000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8187000
CY2014 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
17839000
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
60299000
CY2016 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
19028000
CY2015 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
17739000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
17800000
CY2016Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11561000
CY2016Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10574000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10712000
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
41563000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
721657
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2148797
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1116472
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.42
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.39
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.31
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.56
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8400000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1069923
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.47
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35942000
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32246000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3713000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
4084000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
3299000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
709483
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
129760
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1263425
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
767277
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.92
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3600000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5100000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
824000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
418925
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
300866
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
143187
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
11.15
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.37
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.93
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
486300
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
129000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
162000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5100000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5700000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7900000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8700000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3792162
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3462567
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.33
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.20
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.89
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.78
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.26
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.55
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
768000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-156000
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
451000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y73D
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
577000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y146D
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
6.88
CY2015Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1561916
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
767277
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1116472
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
15.32
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6500000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y146D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y255D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y219D
CY2015Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
9.05
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
8.92
CY2016 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y270D
CY2016 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
56157
CY2015 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
68101
CY2014 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
15769
CY2015Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1819000
CY2014Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1167000
CY2016Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2461000
CY2016 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4733000
CY2015 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3482000
CY2016 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5375000
CY2015 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4134000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
396970
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1141904
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1051138
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1018000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-618000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3307000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10502000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9343000
CY2015 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-40085000
CY2016 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-4873000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
61010000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
50034000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
84265000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
80508000
CY2016Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
3100000
CY2015Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
2800000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
651000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
597000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
535000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
707000
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
56000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
54000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
62000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2016Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
49000
CY2015Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
45000
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13827000
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2016Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
82000
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
78000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of Consolidated Financial Statements in conformity with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates their estimates, including those related to warranty obligation, sales commission, accounts receivable and sales allowances, valuation of inventories, fair values of acquired intangible assets, useful lives of intangible assets and property and equipment, fair values of options to purchase the Company&#x2019;s common stock and other share based awards, recoverability of deferred tax assets, and effective income tax rates, among others. Management bases their estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14201000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13544000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13131000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13010000
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13591000
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13827000
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14441000
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14611000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13753000
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13960000
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14254000
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13591000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13163000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13131000
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13010000
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12978000
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14441000
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14611000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13225000
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13960000
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14254000

Files In Submission

Name View Source Status
0001437749-17-004609-index-headers.html Edgar Link pending
0001437749-17-004609-index.html Edgar Link pending
0001437749-17-004609.txt Edgar Link pending
0001437749-17-004609-xbrl.zip Edgar Link pending
cutr-20161231.xml Edgar Link completed
cutr-20161231.xsd Edgar Link pending
cutr-20161231_cal.xml Edgar Link unprocessable
cutr-20161231_def.xml Edgar Link unprocessable
cutr-20161231_lab.xml Edgar Link unprocessable
cutr-20161231_pre.xml Edgar Link unprocessable
cutr20161231_10k.htm Edgar Link pending
cutr20161231_10kimg002.gif Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending